US 11478542
Immunogenic RSV polypeptides
granted A61KA61K2039/523A61K2039/54
Quick answer
US patent 11478542 (Immunogenic RSV polypeptides) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 17
- CPC classes
- A61K, A61K2039/523, A61K2039/54, A61K2039/55, A61K2039/555